Abstract
As much as 95 to 98% of scleroderma patients have been shown to produce autoantibodies to nuclear, nucleolar or mitochondrial antigens [1–3]. These serologic markers have been shown to be useful in diagnosis and identifying disease subsets [3–5]. A number of autoantigens in scleroderma have been described. The most important are: DNA topoisomerase I (110 kDa) [3, see also this Manual, chapter B-5.1], the centromere proteins CENP-A (17 kDa), CENP-B (80 kDa) and CENP-C (140 kDa) [3, 5, see also this Manual chapter B-5.2], the small nucleolar RNA (snoRNA) associated protein fibrillarin (34 kDa) [3, 5, see also this Manual, chapter B-5.3], the 210 kDa protein component of the RNA polymerase I complex [3, 5], a 40 kDa protein associated with the 7–2 RNP complex [3, 6], nucleolin (110 kDa) [7], a 70 kDa protein of the mitochondrial M2 complex [3, 8], and a nucleolus-organizing region (NOR) associated 90 kDa protein (NOR-90) [3, 9], recently identified as transcription factor hUBF (human upstream binding factor) [10].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bernstein RM, Steigerwald JC & Tan EM (1982) Clin Exp Immunol 48: 43–51
Steen VD, Powell DL & Medsger TA Jr (1988) Arthritis Rheum 31: 196–203
Reimer G (1990) In: LeRoy EC (ed) Rheumatic disease clinics of North America Vol 16(1), pp 169–183. WB Saunders Company, Philadelphia
Tan EM (1982) Adv Inununol 33: 167–240
Tan EM (1989) Adv Immunol 44: 93–152
Kipnis RJ, Craft J & Hardin JA (1990) Arthritis Rheum 33: 1431–1437
Minota S, Jarjour WN, Suziki N, Nojima Y, Roubey RAS, Mimura T, Yamada A, Hosoya T, Takaku F & Winfield JB (1991) J Immunol 146: 2249–2252
Freqeau DR, Leung PSC, Coppel RL, McNeilage LJ, Medsger TA Jr & Gershwin ME (1988) Arthritis Rheum 31: 386–392
Rodriquez-Sanchez JL, Gelpi C, Juarez C & Hardin JA (1987) J Immunol 139: 2579–2584
Chan EKL, Imai H, Hamel JC & Tan EM (1991) J Exp Med 174: 1239–1244
Alderuccio F, Chan EKL & Tan EM (1991) J Exp Med 173: 941–952
Reimer G, Scheer U, Peters J-M & Tan EM (1986) J Immunol 137: 3802–3808
Mimori T, Hardin JA & Steitz JA (1986) J Biol Chem 261: 2274–2278
Reeves WH & Sthoeger ZM (1989) J Biol Chem 264: 5047–5052
Yaneva M, Wen J, Ayala A & Cook R (1989) J Biol Chem 264: 13407–13411
Stuiver MH, Coenjaerts FEJ & van der Vliet PC (1990) J Exp Med 172: 1049–1054
Mimori T, Akizuki M, Yamagata H & Inada S (1981) J Clin Invest 68: 611–620
References
Douvas AS, Achten M & Tan EM (1979) J Biol Chem 254: 10514–10522
Kumar V, Kowalewski C, Koelle M, Qutaishat S, Chorzelski TP, Beutner EH, JarzabekChorzelska M, Kolacinska Z & Jablonska S (1988) J Rheumatol 15: 1499–1502
van Venrooij WJ, Stapel SO, Houben H, Habets WJ, Kallenberg CGM, Penner E & van de Putte LB (1985) J Clin Invest 75: 1053–1060
Tan EM (1982) Adv Immunol 33: 167–240
Tan EM (1989) Adv Immunol 44: 93–152
Maul GG, French BT, van Venrooij WJ & Jiminez SA (1986) Proc Natl Acad Sci USA 83: 5145–5149
Muller MT, Pfund WP, Mehta VB & Trask DK (1985) EMBO J 4: 1237–1243
Oddou P, Schmidt U, Knippers R & Richter A (1988) Eur J Biochem 177: 523–529
Negri C, Chiesa R, Cerino A, Bestagno M, Sala C, Zini N, Maraldi NM & Astaldi Ricotti GCB (1992) Exp Cell Res 200: 452–459
Ghirardello A, Ruffatti A, Calligaro A, Del Ross T & Gambari PF (1992) Clin Rheum 11:126
Hildebrandt S, Weiner E, Senécal J-L, Noell S, Daniels L, Earnshaw WC & Rothfield NF (1990) Arthritis Rheum 33: 724–727
Kipnis RJ, Craft J, Hardin JA (1990) Arthritis Rheum 33: 1431–1437
Juarez C, Vila JL, Gelpi C, Agusti M, Amengual MJ, Martinez MA & Rodriquez JL (1988) Arthritis Rheum 31: 108–115
Hildebrandt S, Noell GS, Vazquez-Abad D, Earnshaw WC, Zanetti M & Rothfield NF (1991) Autoimmunity 10: 41–48
Verheijen R, de Jong BAW & van Venrooij WJ (1992) Clin Exp Immunol 89: 456–460
Heck MMS, Hittelman WN & Earnshaw WC (1988) Proc Natl Acad Sci USA 85: 1086–1090
Wang JC (1985) Ann Rev Biochem 54: 665–697
Osheroff N (1989) Pharmacol Ther 41: 223–241
Meesters TM, Hoet M, van den Hoogen F, Verheijen R, Richter A, Habets WJ & van Venrooij WJ (1992) Mol Biol Rep 16: 117–123
D’Arpa P, Machlin PS, Ratrie H, Rothfield NF, Cleveland DW & Earnshaw WC (1988) Proc Natl Acad Sci USA 85:2543–2547
Kunze N, Yang GC, Jiang ZY, Hameister H, Adolph S, Wiedorn K-H, Richter A & Knippers R (1989) Hum Genet 84: 6–10
Kunze N, Yang G. Dölberg M, Sundarp R, Knippers R & Richter A (1991) J Biol Chem 266: 9610–9616
Maul GG, Jimenez SA, Riggs E & Ziemnicka-Kotula (1989) Proc Natl Acad Sci USA 86: 8492–8496
Zhou BS, Bastow KF & Cheng Y (1989) Cancer Res 49: 3922–3927
Zechiedrich EL & Osheroff N (1990) EMBO J 9: 4555–4562
Barrett JF, Sutcliffe JA & Gootz TD (1990) Antimicrobial Agents and Chemotherapy 34:1–7
Eng W-K, Pandit SD & Sternglanz R (1989) J Biol Chem 264: 13373–13376
Lynn RM, Bjornsti M-A, Caron PR & Wang JC (1989) Proc Natl Acad Sci USA 86: 3559–3563
Hsiang Y-H, Hertzberg R, Hecht S & Liu LF (1985) J Biol Chem 260:14873–14878
Gilmour DS & Elgin SC (1987) Mol Cell Biol 7: 141–148
Zhang H, Wang JC & Liu LF (1988) Proc Natl Acad Sci USA 85: 1060–1064
Douvas A, Lambie PB, Turman MA, Nitahara KS & Hammond L (1991) Biochem Biophys Res Commun 178:414–421
Pommier Y, Kerrigan D, Hartman KD & Glazer RI (1990) J Biol Chem 265: 9418–9422
Samuels DS, Shimizu Y & Shimizu N (1989) FEBS Lett 259: 57–60
Uemura T & Yanagida M (1984) EMBO J 3:1737–1744
Thrash C, Bankier AT, Barrell BG & Sternglanz R (1985) Proc Natl Acad Sci USA 82: 4374–4378
Snapka RM (1986) Mol Cell Biol 6: 4221–4227
Yang L, Wold MS, Li JJ, Kelly TJ & Liu LF (1987) Proc Natl Acad Sci USA 84: 950–954
Bullock P, Champoux JJ & Botchan M (1985) Science 230: 954–958
McCroubrey WK Jr & Champoux JJ (1986) J Biol Chem 261: 5130–5137
Christiansen K, Boven BJ & Westergaard O (1987) J Mol Biol 193: 517–525
Ness JP, Koller T & Thoma F (1988) J Mol Biol 200: 127–139
Gilmour DS, Pflugfelder G, Wang JC & Lis JT (1986) Cell 44: 401–407
Stewart AF & Schütz G (1987) Cell 50: 1109–1117
Verheijen R (1992) Mol Biol Rep 16: 183–189
Verheijen R, van den Hoogen F, Beijer R, Richter A, Penner E, Habets WJ & van Venrooij WJ (1990) Clin Exp Immunol 80: 38–43
D’Arpa P, White-Cooper H, Cleveland DW, Rothfield NF & Earnshaw WC (1990) Arthritis Rheum 33: 1501–1511
Piccinini G, Cardellini E, Reimer G, Arnett FC & Durban E (1991) Mol Immunol 28: 333–339
Kuwana M, Kaburaki J, Mimori T, Tojo T & Homma M (1993) Arthritis Rheum 36: 1406–1413
References
Moroi Y, Peebles C, Fritzler MJ, Steigerwald J & Tan EM (1980) Proc Natl Acad Sci USA 77: 1627–1631
Earnshaw WC & Rothfield N (1985) Chromosoma 91: 313–321
Valdivia MM & Brinkley BR (1985) J Cell Biol 101: 1124–1134
Earnshaw W, Bordwell B, Marino C & Rothfield N (1986) J Clin Invest 77: 426–430
Tan EM (1982) Adv Immunol 33: 167–240
Tan EM (1989) Adv Immunol 44: 93–152
Rothfield N, Whitaker D, Bordwell B, Weiner E, Senécal J-L & Earnshaw W (1987) Arthritis Rheum 30: 1416–1419
Hildebrandt S, Weiner E, Senécal J-L, Noell S, Daniels L, Earnshaw WC & Rothfield NF (1990) Arthritis Rheum 33: 724–727
Muro Y, Sugimoto K, Okazaki T & Ohashi M (1990) J Rheum 17:1042–1047
Earnshaw WC, Sullivan KF, Machlin PS, Cooke CA, Kaiser DA, Pollard TD, Rothfield NF & Cleveland DW (1987) J Cell Biol 104: 817–829
Earnshaw WC, Machlin PS, Bordwell BJ, Rothfield NF & Cleveland DW (1987) Proc Natl Acad Sci USA 84: 4979–4983
Verheijen R, de Jong BAW, Oberyé EHH & van Venrooij WJ (1992) Mol Biol Rep 16: 49–59
Pluta AF, Cooke CA & Earnshaw EC (1990) Trends Biochem 15: 181–185
Willard HF (1990) Trends Genet 6: 410–416
Rattner JB (1991) BioEssays 13: 51–56
Ochs RL & Press RI (1992) Exp Cell Res 200: 339–350
Palmer DK, O’Day K, Wener MH, Andrews BS & Margolis RL (1987) J Cell Biol 104: 805–815
Palmer DK, O’Day K, Trong HL, Charbonneau H & Margolis RL (1991) Proc Natl Acad Sci USA 88: 3734–3738
Masumoto H, Masukata H, Muro Y, Nozaki N & Okazaki T (1989) J Cell Biol 109: 1963–1973
Yoda K, Kitagawa K, Masumoto H, Muro Y & Okazaki T (1992) J Cell Biol 119: 1413–1427
Pluta AF, Saitoh N, Goldberg I & Earnhaw WC (1992) J Cell Biol 116: 1081–1093
Sugimoto K, Muro Y & Himeno M (1992) J Biochem 111: 478–483
Cooke CA, Bernat RL & Earnshaw WC (1990) J Cell Biol 110: 1475–1488
Willard HF & Waye JS (1987) Trends Genet 3: 192–198
Saitoh H. Tomkiel J, Cooke CA, Ratrie H, Maurer M, Rothfield NF & Earnshaw WC (1992) Cell 70: 115–125
Kingwell B & Rattner JB (1987) Chromosoma 95: 403–407
Kremer L, Del Mazo J & Avila J (1988) Eur J Cell Biol 46: 196–199
Palmer DK, O’Day K & Margolis RL (1990) Chromosoma 100: 32–36
Sullivan KF & Glass CA (1991) Chromosoma 100: 360–370
Sugimoto K & Himeno M (1991) Agric Biol Chem. 55: 2687–2692
Verheijen R (1992) Mol Biol Rep 16: 183–189
Rattner JB, Lew J & Wang JH (1990) Cell Motility and the Cytoskeleton 17: 227–236
Moreno S & Nurse P (1990) Cell 61: 549–551
Sturgill TW & Wu J (1991) Biochim Biophys Acta 1092: 350–357
Robbins J, Dilworth SM, Laskey RA & Dingwall C (1991) Cell 64: 615–623
Joly JC, Flynn G & Purich DL (1989) J Cell Biol 109: 2289–2294
Sugimoto K, Migita H, Hagishita Y, Yata H & Himeno M (1992) Cell Structure and Function 17: 129–138
References
Lischwe MA, Ochs RL, Reddy R, Cook RG, Yeoman LC, Tan EM, Reichlin M & Busch H (1985) J Biol Chem 260: 14304–14310
Ochs RL, Lischwe MA, Spohn WH & Busch H (1985) Biol Cell 54: 123–134
Christensen ME, Moloo J, Swischuk JL & Schelling ME (1986) Exp Cell Res 166: 77–93
Schimmang T, Tollervey D, Kern H, Frank R & Hurt EC (1989) EMBO J 8: 4015–4024
Okano Y, Steen VD & Medsger TA Jr (1992) Arthritis Rheum 35: 95–100
Kipnis RJ, Craft J & Hardin JA (1990) Arthritis Rheum 33: 1431–1437
Tyc K & Steitz JA (1989) EMBO J 8: 3113–3119
Verheijen R, Wiik A, de Jong BAW, Heier-Madsen M, Ullman S, Halberg P & van Venrooij WJ (1994) J Immunol Methods 169: 173–182
Puvion-Dutilleul F, Mazan S, Nicoloso M & Christensen ME (1991) Eur J Cell Biol 56: 178–186
Raska I, Andrade LEC, Ochs RL, Chan EKL, Chang CM, Roos G & Tan EM (1991) Exp Cell Res 195: 27–37
Tollervey D, Lehtonen H, Jansen R, Kern H & Hurt EC (1993) Cell 72: 443–457
Filipowicz W & Kiss T. (1993) Mol Biol Rep 18: 149–156
Fournier MJ & Maxwell ES (1993) Trends Biochem 18: 131–135
Mattaj IW, Tollervey D & Séraphin B (1993) FASEB J 7: 47–53
Aris JP & Blobel G (1991) Proc Natl Acad Sci USA 88: 931–935
Turley SJ, Tan EM & Pollard KM (1993) Biochim Biophys Acta 1216: 119–122
Lapeyre B, Mariottini P, Mathieu C, Ferrer P, Amaldi F, Amalric F & Caizergues-Ferrer M (1990) Mol Cell Biol 10: 430–434
Baserga SJ, Yang XW & Steitz JA (1991) EMBO J 10: 2645–2651
Baserga SJ, Gilmore-Hebert M & Yang XW (1992) Genes Dev 6: 1120–1130
Query CC, Bentley RC & Keene JD (1989) Cell 57: 89–101
Bandziulus RJ, Swanson MS & Dreyfuss G (1989) Genes Dev 3: 431–437
Parker KA & Steitz JA (1987) Mol Cell Biol 7: 2899–2913
Celis JE, Rasmusssen HH, Madsen P, et al.(1992) Electrophoresis 13: 893–959
Najbauer J, Johnson BA, Young AL & Aswad DW (1993) J Biol Chem 268: 10501–10509
Reimer G, Pollard KM, Penning CA, Ochs RL, Lischwe MA, Busch H & Tan EM (1987) Arthritis Rheum 30: 793–800
Reuter R, Tessars G, Vohr H-W, Gleichmann E & Lührmann R (1989) Proc Natl Acad Sci USA 86: 237–241
Kiledjian M & Dreyfuss G (1992) EMBO J 11: 2655–2664
Girard J-P, Lehtonen H, Caizergues-Ferrer M, Amalric F, Tollervey D & Lapeyre B (1992) EMBO J 11: 673–682
Russell ID & Tollervey D (1992) J Cell Biol 119: 737–747
Ghisolfi L, Joseph G, Amalric F & Erard M (1992) J Biol Chem 267: 2955–2959
Reddy R & Busch H (1988) In: Birnstiel ML (ed) Structure and Function of Small Nuclear Ribonucleoprotein Particles, pp 1–37. Springer Verlag, Berlin
Kass S, Tyc K, Steitz JA & Sollner-Webb B (1990) Cell 60: 897–908
Savino R & Gerbi SA (1990) EMBO J 8: 2299–2308
Tyc K & Steitz JA (1992) Nucleic Acids Res 20: 5375–5382
Reddy R, Henning D & Busch H (1985) J Biol Chem 260: 10930–10935
Peculis BA & Steitz JA (1993) Cell 73: 1233–1245
Shanab GM & Maxwell ES (1991) Nucleic Acids Res 19: 4891–4894
Liu J & Maxwell ES (1990) Nucleic Acids Res 18: 6565–6571
Leverette R, Andrews M & Maxwell ES (1992) Cell 71: 1215–1221
Fragapane P, Prislei S, Michienzi A, Caffarelli E & Bozzoni I (1993) EMBO J 12: 2921–2929
Fragapane P, Prislei S, Michienzi A, Caffarelli E & Bozzoni I (1993) EMBO J 12: 2921–2929
Christensen ME & Banker N (1992) Cell Biol Int Rep 16: 1119–1131
Tycowski KT, Shu MD & Steitz JA (1993) Genes Dey 7: 1176–1190
References
Reichlin M & Mattioli M (1976) Description of a serological reaction characteristic of polymyositis. Clin Immunol Immunopathol 5: 12–20
Wolfe JF, Adelstein E & Sharp GC (1977) Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 59: 176–178
Bernstein RM, Bunn CC, Hughes GRV, Francoeur AM & Mathews MB (1984) Cellular protein and RNA antigens in autoimmune diseases. Mol Biol Med 2: 105–120
Targoff IN & Reichlin M (1985) Nucleolar localization of the PM-Scl antigen. Arthritis Rheum 28: 226–230
Reimer G, Scheer U, Peters JM & Tan EM (1986) Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/ scleroderma overlap syndromes. J Immunol 137: 3802–3808
Reimer G, Steen VD, Penning CA, Medsger TA & Tan EM (1988) Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31: 525–532
Gelpi C, Alguero A, Angeles Martinez M, Vidal S, Juarez C & Rodriguez-Sanchez JL (1990) Identification of protein components reactive with anti-PM/Sc1 autoantibodies. Clin Exp Immunol 81: 59–64
Kipins RJ, Craft J & Hardin JA (1990) The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum 33: 1431–1437
Alderuccio F, Chan EKL & Tan EM (1991) Molecular characterization of an autoantigen of PM-Scl in the Polymyositis/Scleroderma overlap syndrome: A unique and complete human eDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 173: 941–952
Blüthner M & Bautz FA (1992) Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J Exp Med 176: 973–980
Ge Q, Frank MB, O’Brien C & Targoff IN (1992) Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest 90: 559–570
Bautz FA, Haidmann L & Genth E (1988) Nucleolar autoantibodies in patients with polymyositis-scleroderma overlap syndrome. Z Rheumatol 47: 314
Brendel V, Dohlman J, Blaisdel BE & Karlin S (1991) Very long charge runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci USA 88: 1536–1539
Tan EM (1989) Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44: 93–151
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Van Venrooij, W.J., Maini, R.N. (1994). Scleroderma-associated antigens. In: Van Venrooij, W.J., Maini, R.N. (eds) Manual of Biological Markers of Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5444-4_16
Download citation
DOI: https://doi.org/10.1007/978-94-011-5444-4_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-4243-4
Online ISBN: 978-94-011-5444-4
eBook Packages: Springer Book Archive